BRAF V600E variant detection
GTR Test Accession: Help GTR000571363.1
CANCERDYSMORPHOLOGYENDOCRINOLOGY ... View more
Registered in GTR: 2020-02-28
Last annual review date for the lab: 2024-02-12 LinkOut
At a Glance
Diagnosis; Prognostic; Therapeutic management
Glioma; Melanoma; Non-small cell lung carcinoma more...
Genes (1): Help
BRAF (7q34)
Molecular Genetics - Targeted variant analysis: Digital microfluidic microspheres; PCR
BRAF is a proto-oncogene with roles in cellular proliferation and …
Not provided
Not provided
Ordering Information
Offered by: Help
Laboratory for Molecular Pediatric Pathology
View lab's website
View lab's test page
Test short name: Help
BRAF V600E
Specimen Source: Help
Who can order: Help
  • Licensed Physician
  • Nurse Practitioner
CPT codes: Help
**AMA CPT codes notice
Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Please, contact the Laboratory for Molecular Pediatric Pathology for ordering information.
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Test development: Help
Test developed by laboratory (no manufacturer test name)
Informed consent required: Help
Based on applicable state law
Pre-test genetic counseling required: Help
Decline to answer
Post-test genetic counseling required: Help
Decline to answer
Recommended fields not provided:
Conditions Help
Total conditions: 4
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 2
Method Category Help
Test method Help
Instrument
Targeted variant analysis
Digital microfluidic microspheres
Targeted variant analysis
PCR
BioRad QX200
Clinical Information
Test purpose: Help
Diagnosis; Prognostic; Therapeutic management
Target population: Help
BRAF is a proto-oncogene with roles in cellular proliferation and differentiation. Somatic activating variants are present in numerous malignancies and may contribute to tumorigenesis. Over 90% of BRAF variants occur at a single site and result in a valine-to-glutamate substitution at amino acid 600 (V600E). Droplet digital polymerase chain reaction … View more
Recommended fields not provided:
Technical Information
Test Platform:
None/not applicable
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
Based on internal validation experiments, variant alleles are considered "detected" if they demonstrate variant fractional abundance ≥1%, "indeterminate" if <1% but ≥0.5%, and "not detected" if <0.5%. Therefore this assay may not detect variants with a very low allele fraction or in samples with a very low tumor percentage. For … View more
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Intra-Laboratory
Recommended fields not provided:
Regulatory Approval
FDA Review: Help
Category: Not Applicable
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.